These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16870424)

  • 1. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis.
    Sirohi B; Powles R
    Eur J Cancer; 2006 Jul; 42(11):1671-83. PubMed ID: 16870424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation for amyloidosis.
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
    Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
    Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
    Br J Haematol; 2008 Apr; 141(2):205-11. PubMed ID: 18318761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes.
    Sanchorawala V; Blanchard E; Seldin DC; O'Hara C; Skinner M; Wright DG
    Am J Hematol; 2006 Sep; 81(9):692-5. PubMed ID: 16795060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Rajkumar SV; Lacy MQ; Kyle RA
    Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern treatment of amyloidosis: unresolved questions.
    Dember LM
    J Am Soc Nephrol; 2009 Mar; 20(3):469-72. PubMed ID: 19073820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
    Lahuerta JJ; Mateos MV; Martínez-López J; Rosiñol L; Sureda A; de la Rubia J; García-Laraña J; Martínez-Martínez R; Hernández-García MT; Carrera D; Besalduch J; de Arriba F; Ribera JM; Escoda L; Hernández-Ruiz B; García-Frade J; Rivas-González C; Alegre A; Bladé J; San Miguel JF
    J Clin Oncol; 2008 Dec; 26(35):5775-82. PubMed ID: 19001321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
    Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
    Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment in systemic amyloidosis].
    Ikeda S
    Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Stella-Holowiecka B; Czerw T; Holowiecka-Goral A; Giebel S; Wojnar J; Holowiecki J
    Transplant Proc; 2007 Nov; 39(9):2893-7. PubMed ID: 18022010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.